In patients with advanced uveal melanoma, treatment with the agent selumetinib, compared with chemotherapy, resulted in an improved cancer progression-free survival time and tumor response rate, but no improvement in overall survival. This is according to a study in the June 18 issue of iJAMA/i. The modest improvement in clinical outcomes was accompanied by a high rate of adverse events. Uveal melanoma arises from melanocytes within the choroid ...
Read MoreYou have just read an article categorized health
titled Study Compares Survival for Treatments of Advanced Uveal Melanoma.
Written by:
editor - Thursday, June 19, 2014
There are currently no comments for "Study Compares Survival for Treatments of Advanced Uveal Melanoma"
Post a Comment